NDAORALSUSPENSION
Approved
Jan 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SULFATRIM PEDIATRIC (sulfamethoxazole and trimethoprim) by Inpharmus is cytochrome p450 2c9 inhibitors [moa]. First approved in 1983.
Drug data last refreshed 3d ago
Mechanism of Action
Cytochrome P450 2C9 Inhibitors
Pharmacologic Class:
Sulfonamide Antimicrobial
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Inpharmus
Turkey - Istanbul
Worked on SULFATRIM PEDIATRIC at Inpharmus? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.